The Efficacy of Oral Celecoxib Following Surgical Rhinoplasty
Newberry CI, McCrary HC, Cerrati EW.
What this paper says
Among 51 rhinoplasty patients, the 17 given celecoxib took a mean 4.2 opioid tablets versus 14.8 in controls, a 76.2 percent reduction in opioid milligrams and an 83.4 percent reduction in nausea and vomiting.
Overview
Reducing opioid use after surgery is a stated priority, and non-narcotic alternatives are one route. This prospective cohort study compared patients who received celecoxib, an anti-inflammatory that does not increase bleeding risk in the way older ones do, against those who did not.
Sections of note
- Prospective cohort of 51 consecutive patients who had rhinoplasty between July 2018 and May 2019 by a single facial plastic surgeon.
- A questionnaire on pain medication use and complications was given at the 1-week postoperative visit; patients were grouped by whether celecoxib was used.
- 17 of the 51 patients received celecoxib.
- Mean oxycodone-acetaminophen tablets: 4.2, CI 2.4 to 6.1, versus 14.8 in controls, CI 11.1 to 18.4, p 0.0006.
- Mean oxycodone-acetaminophen dose: 17.6 mg, CI 9.0 to 26.3, versus 73.8 mg, CI 55.5 to 92.0, p 0.0001.
- Mean total oral morphine equivalents: 26.5, CI 13.5 to 39.4, versus 110.7, CI 83.3 to 138.0, p 0.001.
- Nausea and vomiting were significantly reduced, p 0.02; overall a 76.2 percent decrease in opioid milligrams and 83.4 percent decrease in nausea and vomiting, without increased surgical complications. Level of evidence 2.
What it means for a patient
- Adding a non-opioid anti-inflammatory reduced opioid use by roughly three quarters.
- Nausea and vomiting, which are largely opioid side effects, fell correspondingly.
- No increase in surgical complications such as bleeding was reported.
- Limits: 51 patients with only 17 in the treatment group, not randomized, one surgeon, and medication use self-reported at one week.
Why this paper matters
Opioid prescribing after rhinoplasty consistently exceeds what patients need, and a drug that displaces most of it addresses that directly. The effect size here is large. The non-randomized design with a small treatment group means the size of the true effect is uncertain.
Terms
- Celecoxib: An anti-inflammatory painkiller that selectively blocks COX-2.
- Oxycodone-acetaminophen: A common combination tablet of an opioid and paracetamol.
- Oral morphine equivalent: A standard unit allowing different opioids to be compared by strength.
- Prospective cohort: A group tracked forward in time as events occur.
- Perioperative: Around the time of the operation.
Summary written by rhinoplasty.cc from the abstract, 2026-09-09; not medical advice. The authors' own abstract follows.
From the abstract
“Exploring potential methods of controlling postoperative rhinoplasty pain with non-narcotic medications. Objective: To examine the effects of celecoxib in reducing pain and possible opioid consumption after rhinoplasty surgery. Design, Setting, and Participants: This is a prospective cohort study of 51 consecutive…”
Excerpt; the full abstract is on PubMed.
Citation
Start here
This paper sits outside the 16 topic groups; the archive holds every paper by journal and year.
Journal archive by topic
Every topic opens with what the literature says, cited line by line to PubMed.
Papers from 2020
Every paper in the archive published the same year.
Facial Plastic Surgery and Aesthetic Medicine
Papers in the archive from this journal, 2020 to 2026.
Related papers
Same journal, 2020.
- FPSAM A Review and Modification of Dorsal Preservation Rhinoplasty TechniquesPatel PN, Abdelwahab M, Most SP2020PMID 32130066Summary
- FPSAM Complications in Rhinoplasty: A Literature Review and Comparison with a Survey of Consent FormsHeilbronn C, Cragun D, Wong BJF2020PMID 32053419Summary
- FPSAM Evolution of a Rhinoplasty Master: An Interview with Dean Toriumi, MDRhee JS Editor-in-Chief2020PMID 32053420
- FPSAM Keith Needle Technique for Intraoperative Guidance in RhinoplastyLocketz GD, Lozada KN, Bloom JD2020PMID 32212975
- FPSAM Preoperative Computer Simulation in Rhinoplasty Using Previous Postoperative ImagesBashiri-Bawil M, Rahavi-Ezabadi S, Sadeghi M et al.2020PMID 32380871Summary
- FPSAM Prospective Qualitative Multidimensional Assessment of the Postoperative Rhinoplasty ExperienceGadkaree SK, Shaye DA, McCarty JC et al.2020PMID 32223570Summary
- FPSAM Quantifying Aerosolization of Facial Plastic Surgery Procedures in the COVID-19 Era: Safety and Particle Generation in Craniomaxillofacial Trauma and RhinoplastyGadkaree SK, Derakhshan A, Workman AD et al.2020PMID 32628569Summary
- FPSAM Re: "Video Standards for Rhinoplasty Education: A Review and Recommended Guidelines" by Hakimi et alÇelikoyar MM2020PMID 32749869